Werewolf Therapeutics Stock Soars on Ambros Merger Deal
Werewolf Therapeutics stock surged over 100% following the announcement of a merger agreement with Ambros Therapeutics and a concurrent oversubscribed $150 million private placement. This news significantly boosted investor confidence.